Related Experiment Video
Updated: Jun 2, 2026

Curcuminoid-Mediated Antimicrobial Photodynamic Therapy on a Murine Model of Oral Candidiasis
Published on: October 27, 2023
Curcumin acts synergistically with fluconazole to sensitize a clinical isolate of Candida albicans showing a MDR
A S Garcia-Gomes1, J A R Curvelo, R M A Soares
1Laboratório de Bioquímica Microbiana, UFRJ, Rio de Janeiro, Brazil.
Abstract:
The primary objective of this work was to evaluate the capability of curcumin, a natural compound found in the Curcuma longa plant, to sensitize a clinical isolate of Candida albicans, which was found to have a high resistance to fluconazole. In addition, we assessed whether the resistance of this isolate was the result of the existence of efflux pumps, which could confer a multiple drug resistance phenotype. To evaluate azole resistance, we used the Clinical Laboratory Standard Institute (CLSI) MIC assays procedures with minor modifications. For evaluation of synergistic interaction of curcumin and fluconazole, checkerboard experiments were employed. Nile red and Rhodamine 6G accumulation assays were used to evaluate efflux pump activity. Curcumin was found to have a great capability to inhibit fluconazole resistance of the isolate of C. albicans. It was capable of restoring its sensitivity to this azole when used at 11 μM. Analysis with different azoles and the two indicated dyes showed that an efflux pump could be acting and contributing to the resistance of this isolate to fluconazole. The results suggest that a major facilitator superfamily (MFS) transporter might be involved in this process.
Related Concept Videos
Cryptococcal Meningitis
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Candidiasis
Antifungal Agents

